Join the American Thyroid Association’s Surgical Affairs Committee for an expert-led review of the newest ATA guideline recommendations for the initial management of adult patients with differentiated thyroid cancer. Hear from the 2025 Differentiated Thyroid Cancer Guidelines Co-Chairs and leading clinicians as they walk surgeons and endocrinologists through key updates, including extent of surgery, radiofrequency ablation (RFA), and active surveillance. Real case presentations from ATA members will illustrate how these recommendations apply in everyday practice.

What’s New in the 2025 ATA Differentiated Thyroid Cancer Guidelines?
WHO SHOULD ATTEND?
-
Endocrinologists
-
Surgeons and surgical oncologists
-
Nuclear medicine physicians
-
Endocrine fellows & trainees
-
Nurses, physician assistants, and Advanced practice providers
-
Clinicians involved in thyroid cancer diagnosis or management
-
ATA Members
WHY ATTEND?
-
Earn CME
-
Hear directly from guideline co-chairs and authors
-
Understand the major changes impacting initial management
-
Gain practical insight through case-based discussions
-
Gather expert perspectives on surgery, RFA, and active surveillance
-
Take away clear, applicable takeaways for patient care
-
Complimentary for ATA members. Join Today!
HOW TO PARTICIPATE?
Save the date! Registration opens soon.
-
Live webinar: Complimentary for ATA members; $49.00 for non-members
-
Recording: Available March 2025, complimentary for ATA members
Not an ATA member? Join today!
Agenda
-
Welcome & Introductions
-
Overview of the Importance of Guideline Publication
-
Review Recommendations for Extent of Thyroidectomy – Julie Ann Sosa, MD, MA, Chair of Department of Surgery, UCSF
-
Case Presentation – Extent of Surgery
-
Panel Discussion
-
Review Recommendations for Active Surveillance (AS) and RFA – Matthew Ringel, MD, Chair of the Department of Molecular Medicine and Therapeutics,The Ohio State University
-
Case Presentation – PTMC Management (AS vs RFA vs Lobectomy)
-
Panel Discussion
-
Closing Remarks
Continuing Medical Education Credit Information
Accreditation
The American Thyroid Association is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
AMA PRA Category 1 Credits™
The American Thyroid Association designates this live activity for a maximum of 1 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Disclosure Information
In accordance with the ACCME Accreditation Criteria, the American Thyroid Association ensures that anyone in a position to control the content of the educational activity (planners/speakers/authors/discussants/moderators) disclosed all financial relationships with any commercial interest (termed by the ACCME as “ineligible companies”) held in the last 24 months. Disclosures will be made at the beginning of the activity.
The ACCME also requires that ATA manage any reported relevant financial relationships and eliminate the potential for bias during the educational activity. Any relevant financial relationships have been mitigated. The disclosure information is intended to identify any commercial relationships and allow learners to form their own judgments. However, if you perceive a bias during the educational activity, please report it on the evaluation.

